Targeting CSK kinase activity to enhance antitumor immunity

被引：0

作者：

Wang, Cindy ^{[1
]}

Cao, Carolyn ^{[1
]}

Berman-Booty, Lisa ^{[1
]}

Swanson, Jesse ^{[1
]}

Eraslan, Rukiye ^{[1
]}

Sanjuan, Miguel ^{[1
]}

Vite, Gregory ^{[1
]}

Qin, Lan-Ying ^{[1
]}

Hunt, John ^{[1
]}

Fink, Brian ^{[1
]}

Wee, Susan ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Princeton, NJ USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期

关键词：

D O I：

10.1158/1535-7163.TARG-17-B198

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B198

引用

页数：2

共 50 条

[41] Targeting latency-associated peptide promotes antitumor immunity
Gabriely, Galina
da Cunha, Andre P.
Rezende, Rafael M.
Kenyon, Brendan
Madi, Asaf
Vandeventer, Tyler
Skillin, Nathaniel
Rubino, Stephen
Garo, Lucien
Mazzola, Maria A.
Kolypetri, Panagiota
Lanser, Amanda J.
Moreira, Thais
Faria, Ana Maria C.
Lassmann, Hans
Kuchroo, Vijay
Murugaiyan, Gopal
Weiner, Howard L.
SCIENCE IMMUNOLOGY, 2017, 2 (11)
[42] Antitumor activity of sphingosine kinase inhibitors
French, Kevin J.
Upson, John J.
Keller, Staci N.
Zhuang, Yan
Yun, Jong K.
Smith, Charles D.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (02): : 596 - 603
[43] Induction of potent antitumor immunity by in situ targeting of intraturnoral DCs
Furumoto, K
Soares, L
Engleman, EG
Merad, M
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (05): : 774 - 783
[44] Nivolumab: targeting PD-1 to bolster antitumor immunity
Brahmer, Julie R.
Hammers, Hans
Lipson, Evan J.
FUTURE ONCOLOGY, 2015, 11 (09) : 1307 - 1326
[45] Stimulation of antitumor immunity by FoxP3-targeting PROTAC
Wang, Yanping
Zhang, Yi
Su, Shengchen
Tamukong, Patrick
Murali, Ramachandran
Kim, Hyung L.
BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
[46] Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity
Hu, Xiao
Liu, Xikui
Moisan, Jacques
Wang, Yahong
Lesch, Charles A.
Spooner, Chauncey
Morgan, Rodney W.
Zawidzka, Elizabeth M.
Mertz, David
Bousley, Dick
Majchrzak, Kinga
Kryczek, Ilona
Taylor, Clarke
Van Huis, Chad
Skalitzky, Don
Hurd, Alexander
Aicher, Thomas D.
Toogood, Peter L.
Glick, Gary D.
Paulos, Chrystal M.
Zou, Weiping
Carter, Laura L.
ONCOIMMUNOLOGY, 2016, 5 (12):
[47] GENETICALLY ENGINEERED MYELOID CELLS (GEMYS) AS A PLATFORM TO ENHANCE ANTITUMOR IMMUNITY
Kaczanowska, Sabina
Beury, Daniel
Qin, Haiying
Kaplan, Rosandra
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A220 - A220
[48] Multivalent Carbohydrate Nanocomposites for Tumor Microenvironment Remodeling to Enhance Antitumor Immunity
Hyun, Gyu Hwan
Jeong, Da-Hye
Yang, Yoon Young
Cho, In Ho
Ha, Yu-Jin
Xing, Xiaohui
Abbott, D. Wade
Hsieh, Yves S. Y.
Kang, Yun Pyo
Cha, Jong-Ho
Hong, Soon-Sun
Lee, Seul Ji
Kim, You-Sun
Kwon, Sung Won
ACS NANO, 2023, 17 (12) : 11567 - 11582
[49] INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN WITH TEMSIROLIMUS CAN ENHANCE ANTITUMOR IMMUNITY
Wang, Yanping
Kim, Hyung
JOURNAL OF UROLOGY, 2012, 187 (04): : E126 - E126
[50] Reduced C-terminal Src kinase (Csk) activity in colorectal cancer
Rengifo, W
Masaki, T
Igarashi, K
Ikenoue, T
Okamoto, M
Togo, G
Shiratori, Y
Omata, M
GASTROENTEROLOGY, 1999, 116 (04) : A490 - A490

← 1 2 3 4 5 →